Regulus Therapeutics Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Regulus Therapeutics Inc. |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Regulus Therapeutics filed its Q1 2025 10-Q. Financials and operations updated.
AI Summary
Regulus Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company is engaged in the pharmaceutical preparations industry. Key financial details and operational updates for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational status of Regulus Therapeutics, crucial for understanding the company's trajectory in the pharmaceutical sector.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Regulus Therapeutics faces inherent risks related to drug development, clinical trials, regulatory approvals, and market competition.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter for which the report is filed.)
- 20250508 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Regulus Therapeutics Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250508 (date) — Filing date
- SAN DIEGO (location) — City of business and mailing address
- 4224 CAMPUS POINT COURT (address) — Street address of business and mailing
FAQ
What is the primary business of Regulus Therapeutics Inc.?
Regulus Therapeutics Inc. is primarily involved in the Pharmaceutical Preparations industry, as indicated by its SIC code [2834].
What is the fiscal year end for Regulus Therapeutics Inc.?
The fiscal year end for Regulus Therapeutics Inc. is December 31 (1231).
What is the SEC file number for Regulus Therapeutics Inc.?
The SEC file number for Regulus Therapeutics Inc. is 001-35670.
Where is Regulus Therapeutics Inc. located?
Regulus Therapeutics Inc. is located in San Diego, CA, with its business and mailing address at 4224 Campus Point Court, Suite 210.
What period does this 10-Q filing cover?
This 10-Q filing covers the first quarter of 2025, with the period of report ending on March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Regulus Therapeutics Inc..